TGFB2 and neoplasm: A pan-cancer bioinformatic analysis of TGFB2 mRNA showed significant correlations with worse OS and disease-free survival outcomes in PDAC patients analyzed using the TCGA database, and that the TGFB2 mRNA expression levels were also correlated with TAM and cancer-associated fibroblast markers leading to a tumor suppressive and fibrotic TME [33].